-

Vivo Infusion Announces Acquisition of Neurology Institute of San Antonio and Vista Infusions

LAKEWOOD, Colo.--(BUSINESS WIRE)--Vivo Infusion, a nationally recognized provider of accessible and affordable ambulatory infusion services, announced today it has acquired the Neurology Institute of San Antonio (“NISA”) and Vista Infusions (“Vista”) (collectively “the Company”), an industry leader in ambulatory infusion services and a leading neurological center of excellence. With this acquisition, Vivo Infusion will manage nearly 90 ambulatory infusion centers across 15 states. Financial terms of the transaction were not disclosed.

Founded in 2003, the Company provides outstanding patient care to the local community and has grown in the greater San Antonio market through de novo center openings. The Company is a leader as the infusion provider of choice for patients suffering from multiple sclerosis and other neurological conditions. Following the transaction, Vivo will have 20 locations across Texas including infusion centers in Dallas, Houston, Longview, Tyler and San Antonio.

“We are thrilled to continue to build on the reputation of NISA and Vista Infusions and welcome them into the Vivo family,” said Steve Rodgers, Chief Executive Officer of Vivo Infusion. “NISA and Vista continue Vivo’s emphasis as an infusion provider of choice for neurological and autoimmune diseases. We believe that by partnering with leading physician practices like that of Drs. Gazda and Neiman, we can advance the quality of care for patients while improving value. We are delighted to join forces with Drs. Gazda, Neiman, and the entire NISA and Vista teams.”

“I am excited to join the Vivo platform. We look forward to bringing Vivo and Vista together to deliver an industry-leading patient and provider experience,” said Dr. Suzanne Gazda. Dr. Gazda and Dr. Braden Neiman will continue practicing as neurologists with Vivo’s assistance in growth initiatives.

Fifth Third Securities served as the exclusive financial advisor to NISA and Vista Infusions for this transaction.

About Vivo Infusion

Vivo Infusion is a leading provider of accessible, affordable, community-based infusion and injection care for patients suffering from compromised immune systems, cancer-related diagnoses, and other medical conditions. Vivo Infusion provides compassionate, expert care administered in safe, accessible facilities using efficient and cost-effective, patient-focused best practices. Vivo currently serves communities in fifteen states, with plans to expand into additional markets. For more information, visit: https://vivoinfusion.com/.

About NISA and Vista Infusions

Neurology Institute of San Antonio and Vista Infusions is a leading provider of ambulatory infusion services and a neurological center of excellence providing service to patients throughout Texas. The Company specializes in long-term treatment of neurological conditions and has developed a reputation for high quality patient care, professionalism and management of complex conditions in an affordable and accessible setting. For more information, please visit: https://www.vistainfusions.com/.

Contacts

Margot Sala
Senior Vice President National Sales & Marketing
msala@vivoinfusion.com

Vivo Infusion


Release Versions

Contacts

Margot Sala
Senior Vice President National Sales & Marketing
msala@vivoinfusion.com

More News From Vivo Infusion

Vivo Infusion Welcomes Stephan Rodgers as CEO, Positioning Vivo for Continued Market Leadership

DENVER--(BUSINESS WIRE)--Vivo Infusion, a nationally recognized provider of accessible and affordable ambulatory infusion services, announced today the appointment of Stephan Rodgers as the company’s Chief Executive Officer and member of the Board of Directors. Steve will work closely with Chris Reef, Vivo’s outgoing CEO and newly appointed Executive Chairman, to transition leadership responsibilities and continue to build Vivo into the market leader in ambulatory infusion services and trusted...

Vivo Infusion Acquires Infusion Associates

LAKEWOOD, Colo.--(BUSINESS WIRE)--Vivo Infusion, a nationally recognized provider of accessible and affordable ambulatory infusion services, announced today it has acquired Infusion Associates (“the Company”), an industry leader in ambulatory infusion services with centers in Michigan, Minnesota, Ohio and Wisconsin. With this acquisition, Vivo Infusion will manage nearly 80 ambulatory infusion centers across 15 states. Financial terms of the transaction were not disclosed. Founded in 2001, Infu...

Vivo Infusion Acquires Specialty Infusion Centers

DENVER--(BUSINESS WIRE)--Vivo Infusion, a nationally recognized provider of accessible and affordable ambulatory infusion services announced today it has acquired Specialty Infusion, an industry leader in ambulatory infusion and specialty pharmacy services, dedicated to convenient and affordable solutions for infusion patients in 14 ambulatory infusion centers in New York, Massachusetts, and New Jersey. With this acquisition, Vivo Infusion will advance to a combined 55 ambulatory infusion cente...
Back to Newsroom